{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T20:18:11Z","timestamp":1793823491294,"version":"4.6.1"},"reference-count":100,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007311","name":"Deutsche Kinderkrebsstiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007311","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Endocrinology &amp; Metabolism"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.beem.2025.101999","type":"journal-article","created":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T19:39:15Z","timestamp":1744918755000},"page":"101999","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Metabolic complications and their mechanisms in patients with craniopharyngioma"],"prefix":"10.1016","volume":"39","author":[{"given":"Eva Marie","family":"Erfurth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hermann L.","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.beem.2025.101999_bib1","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1210\/er.2013-1115","article-title":"Craniopharyngioma","volume":"35","author":"Muller","year":"2014","journal-title":"Endocr Rev"},{"key":"10.1016\/j.beem.2025.101999_bib2","unstructured":"Santagata S.K.-D.B., Komori T., M\u00fcller H.L., Adamantinomatous craniopharyngioma. In: Brat D.J.G.A., Wesseling P. (editors: Tumours of the sellar region), ed. WHO Classification of Tumours Editorial Board Central nervous system tumours. 5th Edition ed. International Agency for Research on Cancer; 2021.p.393-396. WHO classification of tumours series."},{"issue":"11","key":"10.1016\/j.beem.2025.101999_bib3","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nrendo.2010.168","article-title":"Childhood craniopharyngioma--current concepts in diagnosis, therapy and follow-up","volume":"6","author":"Muller","year":"2010","journal-title":"Nat Rev Endocrinol"},{"issue":"6","key":"10.1016\/j.beem.2025.101999_bib4","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1530\/EJE-15-0709","article-title":"History before diagnosis in childhood craniopharyngioma: associations with initial presentation and long-term prognosis","volume":"173","author":"Hoffmann","year":"2015","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"10.1016\/j.beem.2025.101999_bib5","first-page":"3897","article-title":"Postoperative prognosis in craniopharyngioma with respect to cardiovascular mortality, survival, and tumor recurrence","volume":"83","author":"Bulow","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.beem.2025.101999_bib6","doi-asserted-by":"crossref","DOI":"10.1093\/ejendo\/lvad027","article-title":"Outcome after pediatric craniopharyngioma: the role of age at diagnosis and hypothalamic damage","volume":"188","author":"Beckhaus","year":"2023","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"10.1016\/j.beem.2025.101999_bib7","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/nrendo.2016.217","article-title":"New outlook on the diagnosis, treatment and follow-up of childhood-onset craniopharyngioma","volume":"13","author":"Muller","year":"2017","journal-title":"Nat Rev Endocrinol"},{"issue":"3","key":"10.1016\/j.beem.2025.101999_bib8","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1210\/endrev\/bnac035","article-title":"Contemporary biological insights and clinical management of craniopharyngioma","volume":"44","author":"Apps","year":"2023","journal-title":"Endocr Rev"},{"issue":"1","key":"10.1016\/j.beem.2025.101999_bib9","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41572-022-00351-z","article-title":"Hypothalamic syndrome","volume":"8","author":"M\u00fcller","year":"2022","journal-title":"Nat Rev Dis Prim"},{"issue":"1","key":"10.1016\/j.beem.2025.101999_bib10","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1046\/j.1365-2265.1997.d01-1749.x","article-title":"Increased cerebrovascular mortality in patients with hypopituitarism","volume":"46","author":"Bulow","year":"1997","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"10.1016\/j.beem.2025.101999_bib11","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s11102-012-0428-2","article-title":"Mortality and morbidity in adult craniopharyngioma","volume":"16","author":"Erfurth","year":"2013","journal-title":"Rev Pituit"},{"issue":"2","key":"10.1016\/j.beem.2025.101999_bib12","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1210\/jc.2014-3525","article-title":"Excess mortality and morbidity in patients with craniopharyngioma, especially in patients with childhood onset: a population-based study in Sweden","volume":"100","author":"Olsson","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.beem.2025.101999_bib13","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1365-2265.2005.02231.x","article-title":"Craniopharyngiomas in children and adults: systematic analysis of 121 cases with long-term follow-up","volume":"62","author":"Karavitaki","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"10.1016\/j.beem.2025.101999_bib14","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3171\/jns.2002.97.1.0003","article-title":"Craniopharyngioma in adults and children: a study of 122 surgical cases","volume":"97","author":"Van Effenterre","year":"2002","journal-title":"J Neurosurg"},{"issue":"4","key":"10.1016\/j.beem.2025.101999_bib15","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/j.1365-2265.2010.03838.x","article-title":"Morbidity and mortality in patients with craniopharyngioma after surgery","volume":"73","author":"Crowley","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"10.1016\/j.beem.2025.101999_bib16","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s11060-010-0145-5","article-title":"Late mortality in pediatric patients with craniopharyngioma","volume":"100","author":"Visser","year":"2010","journal-title":"J Neurooncol"},{"issue":"7","key":"10.1016\/j.beem.2025.101999_bib17","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1093\/neuonc\/nov044","article-title":"Survival, hypothalamic obesity, and neuropsychological\/psychosocial status after childhood-onset craniopharyngioma: newly reported long-term outcomes","volume":"17","author":"Sterkenburg","year":"2015","journal-title":"Neuro Oncol"},{"issue":"5","key":"10.1016\/j.beem.2025.101999_bib18","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1530\/EJE-09-0449","article-title":"Hypothalamic involvement predicts cardiovascular risk in adults with childhood onset craniopharyngioma on long-term GH therapy","volume":"161","author":"Holmer","year":"2009","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"10.1016\/j.beem.2025.101999_bib19","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1365-2265.2004.02196.x","article-title":"High prevalence of long-term cardiovascular, neurological and psychosocial morbidity after treatment for craniopharyngioma","volume":"62","author":"Pereira","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"10.1016\/j.beem.2025.101999_bib20","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/cen.14307","article-title":"Brain white matter lesions are associated with reduced hypothalamic volume and cranial radiotherapy in childhood-onset craniopharyngioma","volume":"94","author":"Fjalldal","year":"2021","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"10.1016\/j.beem.2025.101999_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16061099","article-title":"Vascular morbidity and mortality in craniopharyngioma patients-a scoping review","volume":"16","author":"Beckhaus","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.beem.2025.101999_bib22","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-46532-y","article-title":"Vision-related quality of life in patients with childhood-onset craniopharyngioma","volume":"13","author":"Sowithayasakul","year":"2023","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.beem.2025.101999_bib23","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1530\/eje.1.01877","article-title":"The clinical, metabolic and endocrine features and the quality of life in adults with childhood-onset craniopharyngioma compared with adult-onset craniopharyngioma","volume":"152","author":"Kendall-Taylor","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2025.101999_bib24","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1159\/000515318","article-title":"Hypothalamic-pituitary outcome after treatment for childhood craniopharyngioma","volume":"54","author":"van Schaik","year":"2021","journal-title":"Front Horm Res"},{"key":"10.1016\/j.beem.2025.101999_bib25","doi-asserted-by":"crossref","DOI":"10.1093\/ejendo\/lvad009","article-title":"Diagnostic criteria for the hypothalamic syndrome in childhood","author":"van Santen","year":"2023","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"10.1016\/j.beem.2025.101999_bib26","doi-asserted-by":"crossref","first-page":"3972","DOI":"10.1210\/jc.2014-1680","article-title":"Diencephalic syndrome in childhood craniopharyngioma-results of german multicenter studies on 485 long-term survivors of childhood craniopharyngioma","volume":"99","author":"Hoffmann","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.beem.2025.101999_bib27","doi-asserted-by":"crossref","first-page":"5395","DOI":"10.1210\/jc.2010-0993","article-title":"Reduced energy expenditure and impaired feeding-related signals but not high energy intake reinforces hypothalamic obesity in adults with childhood onset craniopharyngioma","volume":"95","author":"Holmer","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.beem.2025.101999_bib28","doi-asserted-by":"crossref","first-page":"5227","DOI":"10.1210\/jc.2002-021797","article-title":"Obesity in patients with craniopharyngioma: assessment of food intake and movement counts indicating physical activity","volume":"88","author":"Harz","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.beem.2025.101999_bib29","doi-asserted-by":"crossref","first-page":"3298","DOI":"10.1210\/jc.2003-031751","article-title":"Longitudinal study on growth and body mass index before and after diagnosis of childhood craniopharyngioma","volume":"89","author":"Muller","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.beem.2025.101999_bib30","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.1210\/jc.2013-2000","article-title":"Hypothalamic involvement predicts cognitive performance and psychosocial health in long-term survivors of childhood craniopharyngioma","volume":"98","author":"Fjalldal","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.beem.2025.101999_bib31","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1148\/radiology.201.3.8939209","article-title":"Diffusion tensor MR imaging of the human brain","volume":"201","author":"Pierpaoli","year":"1996","journal-title":"Radiology"},{"key":"10.1016\/j.beem.2025.101999_bib32","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.brainres.2010.11.072","article-title":"White matter connectivity of human hypothalamus","volume":"1371","author":"Lemaire","year":"2011","journal-title":"Brain Res"},{"issue":"7","key":"10.1016\/j.beem.2025.101999_bib33","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/j.neubiorev.2011.09.005","article-title":"Multiple anatomical systems embedded within the primate medial temporal lobe: implications for hippocampal function","volume":"36","author":"Aggleton","year":"2012","journal-title":"Neurosci Biobehav Rev"},{"issue":"6","key":"10.1016\/j.beem.2025.101999_bib34","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1530\/EJE-18-0081","article-title":"Microstructural white matter alterations and hippocampal volumes are associated with cognitive deficits in craniopharyngioma","volume":"178","author":"Fjalldal","year":"2018","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"10.1016\/j.beem.2025.101999_bib35","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s11060-015-1885-z","article-title":"A systematic review of cognitive performance in patients with childhood craniopharyngioma","volume":"125","author":"Ozyurt","year":"2015","journal-title":"J Neurooncol"},{"issue":"3","key":"10.1016\/j.beem.2025.101999_bib36","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1530\/eje.1.02114","article-title":"Quality of life in treated adult craniopharyngioma patients","volume":"154","author":"Dekkers","year":"2006","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"10.1016\/j.beem.2025.101999_bib37","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1007\/s00381-004-1124-y","article-title":"Longitudinal study on quality of life in 102 survivors of childhood craniopharyngioma","volume":"21","author":"Muller","year":"2005","journal-title":"Childs Nerv Syst"},{"issue":"11","key":"10.1016\/j.beem.2025.101999_bib38","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/S0277-9536(99)00045-3","article-title":"Integrating response shift into health-related quality of life research: a theoretical model","volume":"48","author":"Sprangers","year":"1999","journal-title":"Soc Sci Med"},{"issue":"1-2","key":"10.1016\/j.beem.2025.101999_bib39","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1515\/jpem-2014-0415","article-title":"Eating behavior, weight problems and eating disorders in 101 long-term survivors of childhood-onset craniopharyngioma","volume":"28","author":"Hoffmann","year":"2015","journal-title":"J Pediatr Endocrinol Metab: JPEM"},{"issue":"4","key":"10.1016\/j.beem.2025.101999_bib40","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1055\/s-2001-16855","article-title":"Obesity after childhood craniopharyngioma--German multicenter study on pre-operative risk factors and quality of life","volume":"213","author":"Muller","year":"2001","journal-title":"Multicent Study Klin Padiatr"},{"issue":"5","key":"10.1016\/j.beem.2025.101999_bib41","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1093\/ejendo\/lvae044","article-title":"Long-term weight gain in children with craniopharyngioma","volume":"190","author":"Rovani","year":"2024","journal-title":"Eur J Endocrinol \/ Eur Fed Endocr Soc"},{"key":"10.1016\/j.beem.2025.101999_bib42","doi-asserted-by":"crossref","DOI":"10.1530\/EC-24-0126","article-title":"Impact of parental body mass index at diagnosis on obesity in survivors of pediatric craniopharyngioma","author":"Beckhaus","year":"2024","journal-title":"Endocr Connect"},{"issue":"3","key":"10.1016\/j.beem.2025.101999_bib43","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1210\/endrev\/bnad033","article-title":"Appetite- and weight-regulating neuroendocrine circuitry in hypothalamic obesity","volume":"45","author":"Gan","year":"2024","journal-title":"Endocr Rev"},{"issue":"1","key":"10.1016\/j.beem.2025.101999_bib44","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1210\/er.2018-00017","article-title":"Pathophysiology and individualized treatment of hypothalamic obesity following craniopharyngioma and other suprasellar tumors: a systematic review","volume":"40","author":"van Iersel","year":"2019","journal-title":"Endocr Rev"},{"issue":"2","key":"10.1016\/j.beem.2025.101999_bib45","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1056\/NEJMoa2213329","article-title":"BRAF-MEK Inhibition in Newly Diagnosed Papillary Craniopharyngiomas","volume":"389","author":"Brastianos","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.beem.2025.101999_bib46","article-title":"Sleep disorders in patients with craniopharyngioma: a physiopathological and practical update","volume":"12","author":"Romigi","year":"2021","journal-title":"Front Neurol"},{"key":"10.1016\/j.beem.2025.101999_bib47","first-page":"423","article-title":"Secondary narcolepsy may be a causative factor of increased daytime sleepiness in obese childhood craniopharyngioma patients","volume":"1","author":"Muller","year":"2006","journal-title":"J Pedia Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.beem.2025.101999_bib48","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s11060-020-03519-3","article-title":"Predictors of narcolepsy and hypersomnia due to medical disorder in pediatric craniopharyngioma","volume":"148","author":"Mandrell","year":"2020","journal-title":"J Neurooncol"},{"issue":"10","key":"10.1016\/j.beem.2025.101999_bib49","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.5664\/jcsm.7982","article-title":"Sensitivity and specificity of the modified epworth sleepiness scale in children with craniopharyngioma","volume":"15","author":"Crabtree","year":"2019","journal-title":"J Clin Sleep Med"},{"issue":"4","key":"10.1016\/j.beem.2025.101999_bib50","first-page":"583","article-title":"Melatonin treatment in obese patients with childhood craniopharyngioma and increased daytime sleepiness","volume":"17","author":"Muller","year":"2006","journal-title":"Cancer causes Control: CCC"},{"issue":"8","key":"10.1016\/j.beem.2025.101999_bib51","doi-asserted-by":"crossref","first-page":"3993","DOI":"10.1210\/jcem.87.8.8751","article-title":"Melatonin secretion and increased daytime sleepiness in childhood craniopharyngioma patients","volume":"87","author":"Muller","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.beem.2025.101999_bib52","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1210\/jc.2007-2672","article-title":"Reductions in basal metabolic rate and physical activity contribute to hypothalamic obesity","volume":"93","author":"Shaikh","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.beem.2025.101999_bib53","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3390\/jcm4030389","article-title":"Neuroendocrine disorders in pediatric craniopharyngioma patients","volume":"4","author":"Daubenbuchel","year":"2015","journal-title":"J Clin Med"},{"issue":"5","key":"10.1016\/j.beem.2025.101999_bib54","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1530\/EJE-18-0505","article-title":"Long-term effects of growth hormone replacement therapy in childhood-onset craniopharyngioma: results of the German craniopharyngioma registry (HIT-Endo)","volume":"179","author":"Boekhoff","year":"2018","journal-title":"Eur J Endocrinol \/ Eur Fed Endocr Soc"},{"issue":"2","key":"10.1016\/j.beem.2025.101999_bib55","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s12020-017-1489-9","article-title":"Quality of life and growth after childhood craniopharyngioma: results of the multinational trial KRANIOPHARYNGEOM 2007","volume":"59","author":"Heinks","year":"2018","journal-title":"Endocrine"},{"issue":"6","key":"10.1016\/j.beem.2025.101999_bib56","doi-asserted-by":"crossref","first-page":"P35","DOI":"10.1530\/EJE-21-1186","article-title":"Safety of growth hormone replacement in survivors of cancer and intracranial and pituitary tumours: a consensus statement","volume":"186","author":"Boguszewski","year":"2022","journal-title":"Eur J Endocrinol \/ Eur Fed Endocr Soc"},{"issue":"6","key":"10.1016\/j.beem.2025.101999_bib57","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1530\/EJE-12-0077","article-title":"Tumour recurrence and enlargement in patients with craniopharyngioma with and without GH replacement therapy during more than 10 years of follow-up","volume":"166","author":"Olsson","year":"2012","journal-title":"Eur J Endocrinol \/ Eur Fed Endocr Soc"},{"issue":"5","key":"10.1016\/j.beem.2025.101999_bib58","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/j.1365-2265.2006.02508.x","article-title":"GH replacement does not increase the risk of recurrence in patients with craniopharyngioma","volume":"64","author":"Karavitaki","year":"2006","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.beem.2025.101999_bib59","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.wneu.2017.09.164","article-title":"Physiologic growth hormone-replacement therapy and craniopharyngioma recurrence in pediatric patients: a meta-analysis","volume":"109","author":"Alotaibi","year":"2018","journal-title":"World Neurosurg"},{"key":"10.1016\/j.beem.2025.101999_bib60","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.737743","article-title":"Endocrine disorder in patients with craniopharyngioma","volume":"12","author":"Zhou","year":"2021","journal-title":"Front Neurol"},{"issue":"6","key":"10.1016\/j.beem.2025.101999_bib61","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1055\/s-2003-42722","article-title":"Perioperative dexamethasone treatment in childhood craniopharyngioma--influence on short-term and long-term weight gain","volume":"111","author":"Muller","year":"2003","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"9-10","key":"10.1016\/j.beem.2025.101999_bib62","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1159\/000515347","article-title":"Postoperative and long-term endocrinologic complications of craniopharyngioma","volume":"93","author":"Bereket","year":"2020","journal-title":"Horm Res Paediatr"},{"issue":"1-2","key":"10.1016\/j.beem.2025.101999_bib63","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1159\/000506639","article-title":"Pregnancies after childhood craniopharyngioma: results of KRANIOPHARYNGEOM 2000\/2007 and review of the literature","volume":"111","author":"Sowithayasakul","year":"2021","journal-title":"Neuroendocrinology"},{"issue":"9","key":"10.1016\/j.beem.2025.101999_bib64","article-title":"Eating behaviour and oxytocin in patients with childhood-onset craniopharyngioma and different grades of hypothalamic involvement","volume":"14","author":"Daubenbuchel","year":"2019","journal-title":"Pedia Obes"},{"issue":"2","key":"10.1016\/j.beem.2025.101999_bib65","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1007\/s12020-016-1084-5","article-title":"Oxytocin in survivors of childhood-onset craniopharyngioma","volume":"54","author":"Daubenbuchel","year":"2016","journal-title":"Endocrine"},{"issue":"1","key":"10.1016\/j.beem.2025.101999_bib66","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s12020-017-1257-x","article-title":"First experiences with neuropsychological effects of oxytocin administration in childhood-onset craniopharyngioma","volume":"56","author":"Hoffmann","year":"2017","journal-title":"Endocrine"},{"key":"10.1016\/j.beem.2025.101999_bib67","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.3389\/fonc.2020.01014","article-title":"Social cognition in patients with hypothalamic-pituitary tumors","volume":"10","author":"Ozyurt","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.beem.2025.101999_bib68","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.psyneuen.2017.11.006","article-title":"De-masking oxytocin-deficiency in craniopharyngioma and assessing its link with affective function","volume":"88","author":"Gebert","year":"2018","journal-title":"Psychoneuroendocrinology"},{"issue":"5","key":"10.1016\/j.beem.2025.101999_bib69","doi-asserted-by":"crossref","DOI":"10.1111\/jne.12842","article-title":"Oxytocin release deficit and social cognition in craniopharyngioma patients","volume":"32","author":"Brandi","year":"2020","journal-title":"J Neuroendocrinol"},{"issue":"3","key":"10.1016\/j.beem.2025.101999_bib70","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.ecl.2020.05.009","article-title":"Management of hypothalamic obesity","volume":"49","author":"Muller","year":"2020","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"68","key":"10.1016\/j.beem.2025.101999_bib71","article-title":"Assessment of quality of life in patients with craniopharyngioma and identification of risk factors for compromised overall wellness","volume":"17","author":"Lin","year":"2023","journal-title":"Arch Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.beem.2025.101999_bib72","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1530\/EJE-21-0972","article-title":"Randomized controlled trial of Tesomet for weight loss in hypothalamic obesity","volume":"186","author":"Huynh","year":"2022","journal-title":"Eur J Endocrinol \/ Eur Fed Endocr Soc"},{"issue":"1","key":"10.1016\/j.beem.2025.101999_bib73","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1159\/000495851","article-title":"Treatment of hypothalamic obesity with dextroamphetamine: a case series","volume":"12","author":"Denzer","year":"2019","journal-title":"Obes Facts"},{"issue":"3","key":"10.1016\/j.beem.2025.101999_bib74","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2020-1610","article-title":"Efficacy and safety of metformin for obesity: a systematic review","volume":"147","author":"Masarwa","year":"2021","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.beem.2025.101999_bib75","doi-asserted-by":"crossref","DOI":"10.1111\/cob.12642","article-title":"The role of glucagon-like peptide 1 receptor agonists for weight control in individuals with acquired hypothalamic obesity-a systematic review","volume":"14","author":"Ng","year":"2024","journal-title":"Clin Obes"},{"issue":"3","key":"10.1016\/j.beem.2025.101999_bib76","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/s41366-021-01043-6","article-title":"Energy balance in hypothalamic obesity in response to treatment with a once-weekly GLP-1 receptor agonist","volume":"46","author":"Shoemaker","year":"2022","journal-title":"Int J Obes (Lond)"},{"issue":"7","key":"10.1016\/j.beem.2025.101999_bib77","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1111\/dom.14366","article-title":"MRI measures of hypothalamic injury are associated with glucagon-like peptide-1 receptor agonist treatment response in people with hypothalamic obesity","volume":"23","author":"Perez","year":"2021","journal-title":"Diabetes Obes Metab"},{"issue":"4","key":"10.1016\/j.beem.2025.101999_bib78","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/j.1365-2265.2012.04368.x","article-title":"A glucagon-like peptide-1 (GLP-1) receptor agonist in the treatment for hypothalamic obesity complicated by type 2 diabetes mellitus","volume":"77","author":"Thondam","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"10.1016\/j.beem.2025.101999_bib79","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1159\/000339469","article-title":"Treatment with glucagon-like Peptide-1 agonist exendin-4 in a patient with hypothalamic obesity secondary to intracranial tumor","volume":"78","author":"Simmons","year":"2012","journal-title":"Horm Res Paediatr"},{"issue":"5","key":"10.1016\/j.beem.2025.101999_bib80","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1530\/EJE-12-0997","article-title":"GLP-1 analogues as a new treatment option for hypothalamic obesity in adults: report of nine cases","volume":"168","author":"Zoicas","year":"2013","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"10.1016\/j.beem.2025.101999_bib81","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/dom.14224","article-title":"A phase 3 randomized clinical trial using a once-weekly glucagon-like peptide-1 receptor agonist in adolescents and young adults with hypothalamic obesity","volume":"23","author":"Roth","year":"2021","journal-title":"Diabetes, Obes Metab"},{"key":"10.1016\/j.beem.2025.101999_bib82","doi-asserted-by":"crossref","DOI":"10.1007\/s11102-024-01426-8","article-title":"Semaglutide as a promising treatment for hypothalamic obesity: a six-month case series on four females with craniopharyngioma","author":"Gjersdal","year":"2024","journal-title":"Pituitary"},{"issue":"2","key":"10.1016\/j.beem.2025.101999_bib83","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1210\/jc.2017-02080","article-title":"Oxytocin and naltrexone successfully treat hypothalamic obesity in a boy post-craniopharyngioma resection","volume":"103","author":"Hsu","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.beem.2025.101999_bib84","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvac057","article-title":"Natural history of obesity due to POMC, PCSK1, and LEPR deficiency and the impact of setmelanotide","volume":"6","author":"Wabitsch","year":"2022","journal-title":"J Endocr Soc"},{"issue":"6","key":"10.1016\/j.beem.2025.101999_bib85","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/S2213-8587(24)00087-1","article-title":"Setmelanotide for the treatment of acquired hypothalamic obesity: a phase 2, open-label, multicentre trial","volume":"12","author":"Roth","year":"2024","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"14","key":"10.1016\/j.beem.2025.101999_bib86","article-title":"Could setmelanotide be the game-changer for acquired hypothalamic obesity?","volume":"2024","author":"van Santen","year":"2024","journal-title":"Perspect Front Endocrinol"},{"issue":"6","key":"10.1016\/j.beem.2025.101999_bib87","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1210\/jc.2012-4184","article-title":"Bariatric surgery following treatment for craniopharyngioma: a systematic review and individual-level data meta-analysis","volume":"98","author":"Bretault","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.beem.2025.101999_bib88","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1055\/s-2007-985848","article-title":"First experiences with laparoscopic adjustable gastric banding (LAGB) in the treatment of patients with childhood craniopharyngioma and morbid obesity","volume":"219","author":"Muller","year":"2007","journal-title":"Klin Padiatr"},{"issue":"1","key":"10.1016\/j.beem.2025.101999_bib89","doi-asserted-by":"crossref","first-page":"e426","DOI":"10.1210\/clinem\/dgab567","article-title":"Bariatric interventions in craniopharyngioma patients-best choice or last option for treatment of hypothalamic obesity?","volume":"107","author":"Muller","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.beem.2025.101999_bib90","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1210\/jc.2016-2573","article-title":"Pediatric obesity-assessment, treatment, and prevention: an endocrine society clinical practice guideline","volume":"102","author":"Styne","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"18","key":"10.1016\/j.beem.2025.101999_bib91","first-page":"321","article-title":"The postopera tive quality of life in children and adolescents with craniopharyngioma","volume":"116","author":"Eveslage","year":"2019","journal-title":"Dtsch Arztebl Int"},{"issue":"5","key":"10.1016\/j.beem.2025.101999_bib92","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1530\/EC-19-0074","article-title":"Posterior hypothalamus-sparing surgery improves outcome after childhood craniopharyngioma","volume":"8","author":"Bogusz","year":"2019","journal-title":"Endocr Connect"},{"issue":"8","key":"10.1016\/j.beem.2025.101999_bib93","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/nrendo.2013.125","article-title":"Paediatrics: surgical strategy and quality of life in craniopharyngioma","volume":"9","author":"Muller","year":"2013","journal-title":"Nat Rev Endocrinol"},{"issue":"2","key":"10.1016\/j.beem.2025.101999_bib94","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/sj.ijo.0803074","article-title":"A multicenter, randomized, double-blind, placebo-controlled, dose-finding trial of a long-acting formulation of octreotide in promoting weight loss in obese adults with insulin hypersecretion","volume":"30","author":"Lustig","year":"2006","journal-title":"Int J Obes (Lond)"},{"issue":"8","key":"10.1016\/j.beem.2025.101999_bib95","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/obr.12534","article-title":"The effectiveness of interventions to treat hypothalamic obesity in survivors of childhood brain tumours: a systematic review","volume":"18","author":"Wang","year":"2017","journal-title":"Obes Rev: J Int Assoc Study Obes"},{"issue":"6","key":"10.1016\/j.beem.2025.101999_bib96","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1055\/s-0031-1284420","article-title":"Long-term follow-up of morbidly obese patients with childhood craniopharyngioma after laparoscopic adjustable gastric banding (LAGB)","volume":"223","author":"Muller","year":"2011","journal-title":"Klin Padiatr"},{"issue":"3","key":"10.1016\/j.beem.2025.101999_bib97","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1365-2265.2012.04409.x","article-title":"Bariatric surgery for morbid obesity in craniopharyngioma","volume":"78","author":"Weismann","year":"2013","journal-title":"Clin Endocrinol"},{"issue":"4","key":"10.1016\/j.beem.2025.101999_bib98","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/cen.12031","article-title":"Is bariatric surgery really inefficient in hypothalamic obesity? Case reports letter","volume":"78","author":"Gatta","year":"2013","journal-title":"Clin Endocrinol"},{"issue":"2","key":"10.1016\/j.beem.2025.101999_bib99","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/ijo.2016.195","article-title":"Efficacy and safety of bariatric surgery for craniopharyngioma-related hypothalamic obesity: a matched case-control study with 2 years of follow-up","volume":"41","author":"Wijnen","year":"2017","journal-title":"Int J Obes (Lond)"},{"issue":"5","key":"10.1016\/j.beem.2025.101999_bib100","doi-asserted-by":"crossref","first-page":"595","DOI":"10.4158\/EP15947.OR","article-title":"Hormone substitution after gastric bypass surgery in patients with hypopituitarism secondary to craniopharyngioma","volume":"22","author":"Wolf","year":"2016","journal-title":"Endocr Pr: J Am Coll Endocrinol Am Assoc Clin Endocrinol"}],"container-title":["Best Practice &amp; Research Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X25000326?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X25000326?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T15:36:01Z","timestamp":1760542561000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X25000326"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":100,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S1521690X25000326"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2025.101999","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic complications and their mechanisms in patients with craniopharyngioma","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2025.101999","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101999"}}